Bafna Pharmaceuticals Ltd

🏭 Bafna Pharmaceuticals Sells Chennai Manufacturing Unit to Navron Pharma

- Sale of manufacturing unit at No. 13, S.V. Koil Street, Madhavaram, Chennai - 600060 to Navron Pharma Private Limited.

- Agreement executed on June 23, 2025; transaction completed on June 30, 2025.

- Total consideration received: ₹1,45,13,260.

- Unit contributed ₹11,53,099 (0.08%) to revenue and ₹89,88,267 (1.55%) to net worth as of March 31, 2025.

- Buyer is not related to Bafna's promoter/promoter group/group companies.

- Transaction is not a related party deal and was conducted at arm's length.